Advisor Net Financial, Inc Horizon Therapeutics Public LTD CO Transaction History

Advisor Net Financial, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$98.98 - $115.74 $395 - $462	4 Added 21.05%	23 $2,000
Q2 2023 Jul 14, 2023	SELL	$96.34 - $112.38 $4,527 - $5,281	-47 Reduced 71.21%	19 $1,000
Q1 2023 Apr 28, 2023	BUY	$107.32 - $113.5 $5,044 - $5,334	47 Added 247.37%	66 $7,000
Q4 2022 Jan 13, 2023	SELL	$62.39 - $113.8 $5,053 - $9,217	-81 Reduced 81.0%	19 $0
Q3 2022 Oct 04, 2022	SELL	$58.92 - $84.67 $294 - $423	-5 Reduced 4.76%	100 $6,000
Q2 2022 Jul 07, 2022	BUY	$79.4 - $116.36 $397 - $581	5 Added 5.0%	105 $8,000
Q1 2022 Apr 14, 2022	SELL	$86.42 - $109.81 $2,074 - $2,635	-24 Reduced 19.35%	100 $11,000
Q3 2021 Oct 15, 2021	BUY	$91.91 - $110.37 $11,396 - $13,685	124 New	124 $14,000
Q2 2020 Aug 26, 2020	SELL	$30.2 - $56.98 $9,060 - $17,094	-300 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$24.87 - $38.56 $7,461 - $11,568	300 New	300 $9,000
Q3 2019 Oct 23, 2019	SELL	$23.0 - $27.97 $3,105 - $3,775	-135 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$22.81 - $28.48 $3,079 - $3,844	135 New	135 $3,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.